AARD regulatory event: a positive outcome, +20.3%

On July 30, 2026, Aardvark Therapeutics, Inc. reached its regulatory event. The result was a positive outcome, and the stock moved +20.3% in the window around the event. It had already run +16.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.